» Articles » PMID: 21350196

Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages

Overview
Date 2011 Feb 26
PMID 21350196
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Apolipoprotein E (apoE) exerts potent antiinflammatory effects. Here, we investigated the effect of apoE on the functional phenotype of macrophages.

Methods And Results: Human apoE receptors very-low-density lipoprotein receptor (VLDL-R) and apoE receptor-2 (apoER2) were stably expressed in RAW264.7 mouse macrophages. In these cells, apoE downregulated markers of the proinflammatory M1 phenotype (inducible nitric oxide synthase, interleukin [IL]-12, macrophage inflammatory protein-1α) but upregulated markers of the antiinflammatory M2 phenotype (arginase I, SOCS3, IL-1 receptor antagonist [IL-1RA]). In addition, M1 macrophage responses (migration, generation of reactive oxygen species, antibody-dependent cell cytotoxicity, phagocytosis), as well as poly(I:C)- or interferon-γ-induced production of proinflammatory cytokines; cyclooxygenase-2 expression; and activation of nuclear factor-κB, IκB, and STAT1, were suppressed in VLDL-R- or apoER2-expressing cells. Conversely, the suppression of the M2 phenotype and the enhanced response to poly(I:C) were observed in apoE-producing bone marrow macrophages derived from VLDL-R-deficient mice but not wild-type or low-density lipoprotein receptor-deficient mice. The modulatory effects of apoE on macrophage polarization were inhibited in apoE receptor-expressing RAW264.7 cells exposed to SB220025, a p38 mitogen-activated protein kinase inhibitor, and PP1, a tyrosine kinase inhibitor. Accordingly, apoE induced tyrosine kinase-dependent activation of p38 mitogen-activated protein kinase in VLDL-R- or apoER2-expressing macrophages. Under in vivo conditions, apoE-/- mice transplanted with apoE-producing wild-type bone marrow showed increased plasma IL-1RA levels, and peritoneal macrophages of transplanted animals were shifted to the M2 phenotype (increased IL-1RA production and CD206 expression).

Conclusions: ApoE signaling via VLDL-R or apoER2 promotes macrophage conversion from the proinflammatory M1 to the antiinflammatory M2 phenotype. This effect may represent a novel antiinflammatory activity of apoE.

Citing Articles

Porcine milk small extracellular vesicles modulate peripheral blood mononuclear cell proteome in vitro.

Avila G, Bonnet M, Viala D, Dejean S, Agazzi A, Lecchi C Sci Rep. 2025; 15(1):8069.

PMID: 40055486 PMC: 11889182. DOI: 10.1038/s41598-025-92550-3.


Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk.

Ionescu V, Gheorghe G, Bacalbasa N, Diaconu C Biomolecules. 2025; 15(2).

PMID: 40001466 PMC: 11852489. DOI: 10.3390/biom15020163.


Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma.

Li Y, Lu R, Abuduhailili X, Feng Y J Hepatocell Carcinoma. 2025; 12:301-324.

PMID: 39991517 PMC: 11844312. DOI: 10.2147/JHC.S504078.


Macrophage heterogeneity and oncogenic mechanisms in lung adenocarcinoma: insights from scRNA-seq analysis and predictive modeling.

Zhang H, Dai J, Mu Q, Zhao X, Lin Z, Wang K Front Immunol. 2025; 15():1491872.

PMID: 39850883 PMC: 11754191. DOI: 10.3389/fimmu.2024.1491872.


ApoE Receptor-2 R952Q Variant in Macrophages Elevates Soluble LRP1 to Potentiate Hyperlipidemia and Accelerate Atherosclerosis in Mice.

Turkson V, Haller A, Jaeschke A, Hui D Arterioscler Thromb Vasc Biol. 2024; 45(1):37-48.

PMID: 39508104 PMC: 11668615. DOI: 10.1161/ATVBAHA.124.321748.


References
1.
von der Thusen J, Kuiper J, Van Berkel T, Biessen E . Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev. 2003; 55(1):133-66. DOI: 10.1124/pr.55.1.5. View

2.
van Oosten M, Rensen P, van Amersfoort E, van Eck M, van Dam A, Breve J . Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem. 2001; 276(12):8820-4. DOI: 10.1074/jbc.M009915200. View

3.
Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, STOCKINGER W, Nimpf J . Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell. 1999; 97(6):689-701. DOI: 10.1016/s0092-8674(00)80782-5. View

4.
Roselaar S, Daugherty A . Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res. 1998; 39(9):1740-3. View

5.
De Bont N, Netea M, Demacker P, Kullberg B, van der Meer J, Stalenhoef A . Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Clin Invest. 2000; 30(9):818-22. DOI: 10.1046/j.1365-2362.2000.00715.x. View